Comprehensive 340B experience since the program’s inception.

In crucial areas such as compliance, transactions, advocacy, revenue optimization and reimbursement protection.

FTLF has been a leader in 340B program advocacy since the drug discount program’s inception in 1992. FTLF represents 340B program stakeholders, focusing primarily on covered entity grantees including federally-qualified health centers, Ryan White HIV/AIDS Program providers, hemophilia treatment centers, and family planning clinics, and on hospitals eligible for the program, including disproportionate share hospitals, children’s hospitals, critical access hospitals, and other rural medical centers. FTLF prides itself on being on the cutting edge of care delivery models, including telemedicine, patient-centered medical care, chronic disease management and clinical pharmacy services.

FTLF advocates on behalf of covered entities and the pharmacies and administrators that support them before HRSA and its Office of Pharmacy Affairs, and state and federal lawmakers. FTLF is proud to be instrumental in developing 340B program protections at the state and federal levels, including enacted legislation in multiple states. Through its work for the National Association of Community Health Centers (NACHC) and 340B Coalition, FTLF is always abreast of the latest 340B program developments.

We have handled scores of transactional matters relating to the 340B program, including contract pharmacy agreements, third party administrator (TPA) agreements, independent audit engagements, and other partnerships involving our clients.

FTLF also fights for covered entities in disputes with government agencies, vendors, and drug manufacturers. FTLF is a pioneer in bringing dispute resolution claims before HRSA when drug manufacturers violate their program obligations.

Lastly, FTLF believes strongly in compliance preparedness, offering multiple trainings and webinars throughout the year on 340B program compliance and management topics. The firm can audit policies and procedures and perform compliance audits directly or by engaging experienced compliance reviewers for our clients.

If you have questions, please contact: Michael B. Glomb at